PWAM
ABBV icon

Papamarkou Wellner Asset Management’s AbbVie ABBV Stock Holding History

Papamarkou Wellner Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.21M Hold
10,063
– – 1.39% 24
2026
Q1 		$2.19M Buy
10,063
+452
+5% +$100K 1.34% 25
2025
Q4 		$2.2M Buy
9,611
+52
+0.5% +$11.8K 1.32% 24
2025
Q3 		$2.21M Hold
9,559
– – 1.37% 24
2025
Q2 		$1.77M Buy
9,559
+1,098
+13% +$204K 1.17% 29
2025
Q1 		$1.77M Sell
8,461
-582
-6% -$113K 1.23% 30
2024
Q4 		$1.61M Buy
+9,043
New +$1.66M 1.11% 33

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Papamarkou Wellner Asset Management's ABBV Position: Q2 2026 in Review

Papamarkou Wellner Asset Management held its AbbVie (ABBV) position steady in Q2 2026 at 10,063 shares worth $2.21M. The position accounts for 1.39% of the portfolio, ranked #24.

Papamarkou Wellner Asset Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.21M in Q3 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Papamarkou Wellner Asset Management held 10,063 shares of AbbVie worth $2.21M as of Q2 2026.
  • Papamarkou Wellner Asset Management left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 1.39% of Papamarkou Wellner Asset Management's portfolio in Q2 2026, its #24 holding.
  • Papamarkou Wellner Asset Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Papamarkou Wellner Asset Management's AbbVie position peaked at $2.21M in Q3 2025.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Papamarkou Wellner Asset Management's 13F filing for Q2 2026, filed 17 Aug 2026.